GENE ONLINE|News &
Opinion
Blog

SARS-CoV-2
Antibody Treatment for Multiple Varieties of CoronaVirus
2022-08-16
Novel Inhalable COVID-19 Therapeutic Targeting Viral Replication
2022-08-10
The Absence of Long COVID Treatment Plans Has Become a New Business Opportunity for Medium-sized Pharmas
2022-03-30
If It Works, Replicate It: Generic COVID-19 Drugs
2022-03-28
FDA Gives Emergency Approval for Lilly’s Anti-Omicron Antibody Treatment
2022-02-14
New Study Suggests Vaccines Protect against Long COVID
2022-01-28
Concerns Remain as Kintor Pharma’s Proxalutamide Shows Unbelievably High Efficacy Against Covid-19 Infections in Phase 3 Trials
2022-01-16
Pfizer’s COVID-19 Oral Antiviral Cuts Hospitalization and Death By 89%
2021-11-05
New Study Supports Llama Nanobodies As Potential COVID-19 Treatment
2021-09-23
Pfizer/BioNTech’s COVID-19 Vaccine Notches Full Approval from USFDA
2021-08-23
This CRISPR-Based Test Can Detect COVID-19 Variants From Your Spit
2021-08-13
Reprogrammed CRISPR Tool Could Target Emerging SARS-CoV-2 Variants
2021-07-28
Korea Receives 700,000 COVID-19 Vaccines from Israel Under a Swap Deal
2021-07-06
FDA Authorizes Pfizer/BioNTech’s COVID-19 Vaccine for 12 to 15 Year Olds
2021-05-11
India Approves Oral COVID-19 Drug for Emergency Use to Abate Oxygen Crisis
2021-05-09
1 2 3 9
LATEST
NDA for Biogen-Sage’s Zuranolone Accepted by FDA, Marking Another Step Forward in Depression Drug Development
2023-02-07
BMS Returns $475 Million Cancer Asset To Dragonfly Therapeutics
2023-02-07
FDA Expands Approval For Takeda’s Takhzyro To Prevent Hereditary Angioedema Attacks
2023-02-06
Abbott’s New Technologies for Arrhythmia Treatment Secure FDA and European Approval
2023-02-04
First Human Trial for Marburg Virus Vaccine Reports Success
2023-02-03
Karuna Licenses Goldfinch’s Mood Disorder Candidates For Potential $535 Million
2023-02-03
Novel Bioengineered Wearable Edgeless Skin Brings Hope to Revolutionize Plastic and Reconstructive Surgery
2023-02-03
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!